Amerson Erin, Woodruff Carina Martin, Forrestel Amy, Wenger Megan, McCalmont Timothy, LeBoit Philip, Maurer Toby, Laker-Oketta Miriam, Muyindike Winnie, Bwana Mwebesa, Buziba Nathan, Busakhala Naftali, Wools-Kaloustian Kara, Martin Jeffrey
*Department of Dermatology, University of California-San Francisco, San Francisco, CA; †Yale School of Medicine, New Haven, CT; ‡Department of Dermatology, University of Pennsylvania, Philadelphia, PA; §Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA; ‖Department of Pathology and Laboratory Medicine, University of California-San Francisco, San Francisco, CA; ¶Infectious Disease Institute, Makerere University, Kampala, Uganda; #Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; **Department of Pathology, Moi University School of Medicine, Eldoret, Kenya; ††Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya; ‡‡Department of Hematology and Oncology, Moi Teaching and Referral Hospital, Eldoret, Kenya; and §§Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):295-301. doi: 10.1097/QAI.0000000000000862.
HIV-associated Kaposi sarcoma (KS) is one of the most common malignancies in sub-Saharan Africa. The diagnosis is often based on clinical suspicion, without histopathologic confirmation. When biopsies are performed, the accuracy of interpretation by local pathologists is poorly understood. We assessed the accuracy of clinical suspicion and pathologic diagnosis of KS in 2 East African countries.
At 2 large HIV care sites in Uganda and Kenya, we evaluated consecutive biopsies performed from October 2008 to January 2013 on HIV-infected adults with clinically suspected KS. Biopsies were interpreted by both local African pathologists and a group of US-based dermatopathologists from a high volume medical center. For the purpose of this analysis, the US-based dermatopathologist interpretation was used as the gold standard. Positive predictive value was used to characterize accuracy of local African clinical suspicion of KS, and concordance, sensitivity, and specificity were used to characterize accuracy of local pathologic diagnosis.
Among 1106 biopsies, the positive predictive value of clinical suspicion of KS was 77% (95% confidence interval: 74% to 79%). When KS was not histopathologically diagnosed, clinically banal conditions were found in 35%, medically significant disorders which required different therapy in 59% and life-threatening diseases in 6%. Concordance between African pathologists and US-based dermatopathologists was 69% (95% confidence interval: 66% to 72%). Sensitivity and specificity of African pathologic diagnoses were 68% and 89%, respectively.
Among East African HIV-infected patients, we found suboptimal positive predictive value of clinical suspicion of KS and specific, but not sensitive, histopathologic interpretation. The findings call for abandonment of isolated clinical diagnosis of KS in the region and augmentation of local dermatopathologic services.
与人类免疫缺陷病毒(HIV)相关的卡波西肉瘤(KS)是撒哈拉以南非洲最常见的恶性肿瘤之一。诊断通常基于临床怀疑,而无组织病理学确诊。进行活检时,当地病理学家的解读准确性尚不清楚。我们评估了两个东非国家KS临床怀疑和病理诊断的准确性。
在乌干达和肯尼亚的两个大型HIV治疗点,我们评估了2008年10月至2013年1月期间对临床怀疑患有KS的HIV感染成人进行的连续活检。活检由当地非洲病理学家和一组来自大型医疗中心的美国皮肤病理学家进行解读。为进行此分析,将美国皮肤病理学家的解读用作金标准。阳性预测值用于描述当地非洲人对KS临床怀疑的准确性,一致性、敏感性和特异性用于描述当地病理诊断的准确性。
在1106例活检中,KS临床怀疑的阳性预测值为77%(95%置信区间:74%至79%)。当未通过组织病理学诊断出KS时,35%发现为临床常见情况,59%为需要不同治疗的具有医学意义的疾病,6%为危及生命的疾病。非洲病理学家与美国皮肤病理学家之间的一致性为69%(95%置信区间:66%至72%)。非洲病理诊断的敏感性和特异性分别为68%和89%。
在东非HIV感染患者中,我们发现KS临床怀疑的阳性预测值不理想,组织病理学解读具有特异性但不敏感。这些发现呼吁放弃该地区KS的单纯临床诊断,并加强当地皮肤病理学服务。